Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Participatory Medicine

Date Submitted: Jul 29, 2020
Open Peer Review Period: Jul 29, 2020 - Sep 23, 2020
Date Accepted: Dec 12, 2020
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Data Sharing Goals for Nonprofit Funders of Clinical Trials

Coetzee T, Ball MP, Boutin M, Bronson A, Dexter DT, English RA, Furlong P, Goodman AD, Grossman C, Hernandez AF, Hinners JE, Hudson L, Kennedy A, Marchisotto MJ, Myers B, Nowell WB, Nosek BA, Sherer T, Shore C, Sim I, Smolensky L, Williams C, Wood J, Terry SF

Data Sharing Goals for Nonprofit Funders of Clinical Trials

J Particip Med 2021;13(1):e23011

DOI: 10.2196/23011

PMID: 33779573

PMCID: 8088851

Statement of Data Sharing Goals for Nonprofit Funders of Clinical Trials

  • Timothy Coetzee; 
  • Mad Price Ball; 
  • Marc Boutin; 
  • Abby Bronson; 
  • David T. Dexter; 
  • Rebecca A. English; 
  • Pat Furlong; 
  • Andrew D. Goodman; 
  • Cynthia Grossman; 
  • Adrian F. Hernandez; 
  • Jennifer E. Hinners; 
  • Lynn Hudson; 
  • Annie Kennedy; 
  • Mary Jane Marchisotto; 
  • Betsy Myers; 
  • W. Benjamin Nowell; 
  • Brian A. Nosek; 
  • Todd Sherer; 
  • Carolyn Shore; 
  • Ida Sim; 
  • Luba Smolensky; 
  • Christopher Williams; 
  • Julie Wood; 
  • Sharon F. Terry

ABSTRACT

Sharing clinical trial data can provide value to research participants and communities by accelerating the development of new knowledge and therapies as investigators merge data sets to conduct new analyses, reproduce published findings to raise standards for original research, and learn from the work of others to generate new research questions. As a voice for the perspective of participants in clinical trials, nonprofit funders – including disease advocacy and patient-focused organizations – play a pivotal role in the promotion and implementation of data sharing policies. Funders are uniquely positioned to promote and support a culture of data sharing by serving as trusted liaisons between potential research participants and investigators who wish to access these participant networks for clinical trial recruitment. In short, nonprofit funders can drive policies and influence research culture. The purpose of this statement is to detail a set of aspirational goals and forward-thinking, collaborative solutions to data sharing for nonprofit funders to fold into existing funding policies. The goals in this statement convey the complexity of the opportunities and challenges facing nonprofit funders and the appropriate prioritization of data sharing within their organizations and may serve as a starting point for a data sharing “toolkit” for nonprofit funders of clinical trials, to provide the clarity of mission and mechanisms to enforce the data sharing practices their communities already expect are happening.


 Citation

Please cite as:

Coetzee T, Ball MP, Boutin M, Bronson A, Dexter DT, English RA, Furlong P, Goodman AD, Grossman C, Hernandez AF, Hinners JE, Hudson L, Kennedy A, Marchisotto MJ, Myers B, Nowell WB, Nosek BA, Sherer T, Shore C, Sim I, Smolensky L, Williams C, Wood J, Terry SF

Data Sharing Goals for Nonprofit Funders of Clinical Trials

J Particip Med 2021;13(1):e23011

DOI: 10.2196/23011

PMID: 33779573

PMCID: 8088851

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.